Wells Fargo’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-58,882
| Closed | -$223K | – | 6757 |
|
|
2020
Q1 | $223K | Sell |
58,882
-97,264
| -62% | -$368K | ﹤0.01% | 4452 |
|
|
2019
Q4 | $795K | Buy |
156,146
+41,668
| +36% | +$212K | ﹤0.01% | 3940 |
|
|
2019
Q3 | $579K | Buy |
114,478
+1,305
| +1% | +$6.6K | ﹤0.01% | 4168 |
|
|
2019
Q2 | $698K | Sell |
113,173
-459,192
| -80% | -$2.83M | ﹤0.01% | 4064 |
|
|
2019
Q1 | $2.66M | Buy |
572,365
+458,070
| +401% | +$2.13M | ﹤0.01% | 3101 |
|
|
2018
Q4 | $481K | Buy |
114,295
+3,517
| +3% | +$14.8K | ﹤0.01% | 4235 |
|
|
2018
Q3 | $695K | Buy |
110,778
+3,777
| +4% | +$23.7K | ﹤0.01% | 4135 |
|
|
2018
Q2 | $860K | Sell |
107,001
-73,756
| -41% | -$593K | ﹤0.01% | 4033 |
|
|
2018
Q1 | $1.35M | Sell |
180,757
-33,866
| -16% | -$253K | ﹤0.01% | 3629 |
|
|
2017
Q4 | $1.28M | Buy |
214,623
+5,807
| +3% | +$34.6K | ﹤0.01% | 3690 |
|
|
2017
Q3 | $1.54M | Buy |
208,816
+44,658
| +27% | +$329K | ﹤0.01% | 3458 |
|
|
2017
Q2 | $1.12M | Sell |
164,158
-22,654
| -12% | -$154K | ﹤0.01% | 3597 |
|
|
2017
Q1 | $1.76M | Sell |
186,812
-13,646
| -7% | -$129K | ﹤0.01% | 3277 |
|
|
2016
Q4 | $1.73M | Buy |
200,458
+127,142
| +173% | +$1.1M | ﹤0.01% | 3227 |
|
|
2016
Q3 | $464K | Buy |
73,316
+360
| +0.5% | +$2.28K | ﹤0.01% | 3884 |
|
|
2016
Q2 | $308K | Sell |
72,956
-5,700
| -7% | -$24.1K | ﹤0.01% | 4049 |
|
|
2016
Q1 | $343K | Buy |
78,656
+3,086
| +4% | +$13.5K | ﹤0.01% | 3989 |
|
|
2015
Q4 | $463K | Buy |
75,570
+55,803
| +282% | +$342K | ﹤0.01% | 3864 |
|
|
2015
Q3 | $113K | Sell |
19,767
-17,088
| -46% | -$97.7K | ﹤0.01% | 4625 |
|
|
2015
Q2 | $276K | Buy |
36,855
+31,332
| +567% | +$235K | ﹤0.01% | 4300 |
|
|
2015
Q1 | $33K | Buy |
5,523
+2,297
| +71% | +$13.7K | ﹤0.01% | 4988 |
|
|
2014
Q4 | $24K | Buy |
3,226
+26
| +0.8% | +$193 | ﹤0.01% | 5082 |
|
|
2014
Q3 | $17K | Sell |
3,200
-3,154
| -50% | -$16.8K | ﹤0.01% | 5218 |
|
|
2014
Q2 | $27K | Buy |
+6,354
| New | +$27K | ﹤0.01% | 5097 |
|